Results 141 to 150 of about 42,337 (292)

Myelodysplastic syndrome [PDF]

Canadian Medical Association Journal, 2016
Richard A, Wells, Rena, Buckstein, Jeremy, Rezmovitz   +2 more
openaire   +2 more sources

Significance of Myelodysplasia‐Related Mutations and the Genetic Landscape of Acute Leukemias of Ambiguous Lineage

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT The recent fifth edition WHO classification and ICC classification systems have moved further toward genetically defined classifications of acute leukemias. Both now recognize myelodysplasia‐related (MR) mutations as defining of MDS‐related AML (AML‐MR).
Timothy J. Kirtek, Olga K. Weinberg
wiley   +1 more source

Advancing drug development in myelodysplastic syndromes. [PDF]

Blood Adv
Mina A, McGraw KL, Cunningham L, Kim N, Jen EY, Calvo KR, Ehrlich LA, Aplan PD, Garcia-Manero G, Foran JM, Garcia JS, Zeidan AM, DeZern AE, Komrokji R, Sekeres MA, Scott B, Buckstein R, Tinsley-Vance S, Verma A, Wroblewski T, Pavletic S, Norsworthy K.   +21 more
europepmc   +1 more source

Hypermethylation of the p15INK4B Gene in Myelodysplastic Syndromes [PDF]

, 1997
Toshiki Uchida, Tomohiro Kinoshita, Hirokazu Nagai, Y Nakahara, Hidehiko Saito, Tomomitsu Hotta, Takashi Murate   +6 more
openalex   +1 more source

Myelodysplastic Syndromes [PDF]

Mayo Clinic Proceedings, 2015
openaire   +1 more source

Common Hematologic Emergencies—Acute Promyelocytic Leukemia and Microangiopathic Hemolytic Anemias—A Pivotal Role of Clinical Laboratory

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Hematologic emergencies are urgent health conditions which result in significant mortality and morbidity unless timely therapeutic measures are taken. Therapeutic success depends on their timely and accurate recognition by hematology laboratory services.
Ganna Shestakova, Nicolas Ulrich Edgar, Anton V. Rets   +2 more
wiley   +1 more source

Distinct routes of clonal progression in SF3B1-mutant myelodysplastic syndromes. [PDF]

Blood Adv
Sarchi M, Clough CA, Gallì A, Picone C, Ferrari B, Crosse EI, Baquero Galvis LD, Fiducioso C, Aydinyan N, Creamer JP, Pozzi S, Molteni E, Elena C, Bradley RK, Malcovati L, Doulatov S.   +15 more
europepmc   +1 more source

Translation of the Morphological Hallmarks of Dyserythropoiesis to Objective Morphometric Parameters by Imaging Flow Cytometry

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction Imaging flow cytometry (IFC) is a unique method combining multiparameter flow cytometry (MFC) with morphological evaluation of single cells. Since both analyses are integrated in the diagnostic work‐up of myelodysplastic neoplasms (MDS), we wanted to explore the possibilities of IFC as a diagnostic tool for MDS, with focus on ...
D. V. Despoina Violidaki, O. A. Olof Axler, L. N. Lars Nilsson, A. P. Anna Porwit, M. E. Mats Ehinger   +4 more
wiley   +1 more source

Progress in the Genetics of Myelodysplastic Syndromes with a Latin American Perspective. [PDF]

Genes (Basel)
Basquiera AL, Andreoli V, Grille S, Belli CB.   +3 more
europepmc   +1 more source

Design, implementation and evaluation of a model of care for patients with germline predisposition to haematological malignancy and bone marrow failure syndromes

Internal Medicine Journal, EarlyView.
Abstract Background The bone marrow failure syndromes (BMFS) are clinically heterogeneous conditions with both inherited and acquired etiologies. Optimal care is often challenged by the complexity of these disorders and gaps in healthcare delivery.
Lucy C. Fox, Erin Goode, Nicole Den Elzen, Lin Cheng, Laura Barth, Kelsey Man, Anna Jarmolowicz, Mary Panjari, Stephanie Best, Karin Thursky, Paul James, Ashish Bajel, David Ritchie, Piers Blombery   +13 more
wiley   +1 more source